The question about the street value of hydromorphone cannot be answered with the provided information. This query falls outside the scope of information typically tracked by drug patent and exclusivity databases.
What is Hydromorphone?
Hydromorphone is an opioid analgesic used to treat moderate to severe pain. It is a Schedule II controlled substance in the United States, meaning it has a high potential for abuse and dependence [1].
How is Hydromorphone Typically Prescribed?
Hydromorphone is available in various forms, including oral tablets, capsules, and solutions, as well as injectable and rectal preparations. It is prescribed by healthcare professionals for patients experiencing significant pain, often post-surgery or due to chronic conditions [1].
What are the Risks Associated with Hydromorphone Use?
Like other opioids, hydromorphone carries risks of addiction, abuse, overdose, and respiratory depression. It can also cause side effects such as drowsiness, dizziness, constipation, and nausea [1].
What is Drug Patent Information?
Drug patent information, such as that provided by DrugPatentWatch.com, tracks the intellectual property rights granted to pharmaceutical companies for their drug discoveries. This includes patents on the drug itself, its manufacturing process, and its uses [2]. This information is crucial for understanding when a drug may become available as a generic medication.
How Do Patents Affect Drug Availability?
Drug patents grant exclusivity to the innovator company for a specific period, preventing other companies from manufacturing and selling the same drug. Once a patent expires, or if it is successfully challenged, other manufacturers may be able to produce and market generic versions, which are typically less expensive [2].